相关实验视频
Updated: Jun 11, 2025

05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
1.3K
阿尔法上腺抗剂和虹膜动态:白内障手术中的挑战和解决方案
Jaya Kaushik1, Rishi Sharma1, Sumit Goyal2
1Dept of Ophthalmology, Command Hospital (CC), Lucknow, India.
BMC ophthalmology
|October 4, 2024
概括
阿尔法-1上腺素受体抗剂 (α1-ARA) 影响虹膜参数,可能使白内障手术复杂化. 对于医生和患者来说,意识到这些影响至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔法-1上腺素受体抗剂 (α1-ARA) 广泛用于高血压和良性前列腺缩 (BPH).
- 像坦素这样的α1-ARA与白内障手术期间的手术风险增加有关.
- 这项研究研究了α1-ARA对虹膜特征和白内障手术挑战的影响.
研究的目的:
- 评估α1-ARA对虹膜参数的影响.
- 评估α1-ARA与白内障手术中的手术挑战之间的相关性.
主要方法:
- 一项前性,横截面研究比较了接受白内障手术的30名α1-ARA患者和30名匹配的对照.
- 在两组中都评估了虹膜参数和外科手术挑战.
主要成果:
- 接受α1-ARA治疗的患者的瞳孔直径显著减少.
- 在接受治疗的组中,在扩张肌肉区域 (DMR) 的虹膜厚度显著减少,DMR/SMR比率较低.
- 较长时间的α1-ARA治疗与减少的DMR/SMR比率相关.
结论:
- α1-ARAs显著影响瞳孔尺寸调节和虹膜结构,可能导致手术内松动虹膜综合征 (IFIS).
- 与alfuzosin相比,tamsulosin在诱导IFIS方面显示出更大的功效.
- 眼科医生,泌尿科医生和初级保健医生必须意识到这些药物诱导的影响,以减轻白内障手术并发症.
相关概念视频
Open Angle Glaucoma: Treatment
403
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
403
Angle Closure Glaucoma: Treatment
448
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
448
Adrenergic Agonists: Therapeutic Uses
743
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
743
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
540
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
540
Direct-Acting Cholinergic Agonists: Therapeutic Uses
702
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
702
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
558
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
558

